Eris Lifesciences Limited — Dividend/Bonus, 07-02-2025: Dividend

Eris Lifesciences has announced a board meeting to declare an interim dividend of ₹7.35 (at a 735% rate) per fully paid-up equity share of ₹1 for the financial year 2024-2025. The record date to determine eligibility for the dividend is set for February 13, 2025, with payment to be made to eligible shareholders on or before March 9, 2025. This interim dividend demonstrates the company's ongoing commitment to returning value to its shareholders.